Intrauterine Misoprostol Versus Intravenous Oxytocin for the Prevention of Primary Postpartum Hemorrhage During Cesarean Section: A One-Year Randomized Controlled Trial. Eastern Med. Coll. J. 2026;10(2):111-115. doi:10.3329/emcj.v10i2.85706